← Back to Search

Behavioral Intervention

Activity monitoring for Mild Cognitive Impairment (mSIM Trial)

N/A
Waitlist Available
Led By Jennifer Bramen, PhD
Research Sponsored by John Wayne Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, approximately 3 months and approximately 6 months
Awards & highlights

mSIM Trial Summary

This trial is looking at whether or not a mobile-based program that helps with both exercise and memory skills training is effective for people with mild cognitive impairment.

Eligible Conditions
  • Mild Cognitive Impairment (MCI)

mSIM Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, approximately 3 months and approximately 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, approximately 3 months and approximately 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Functional Abilities
Memory Function Composite Score
Secondary outcome measures
Resting brain-derived neurotrophic factor (BDNF)
Resting norepinephrine (NE)

mSIM Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group 2 (Experimental)Experimental Treatment1 Intervention
Group 2: Participants will receive the mSIM treatment and have their activity monitored continuously (via Fitbit)
Group II: Group 1 (No treatment)Active Control1 Intervention
Group 1: Participants will have continuous activity monitoring (via Fitbit)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Activity monitoring
2013
N/A
~130

Find a Location

Who is running the clinical trial?

John Wayne Cancer InstituteLead Sponsor
21 Previous Clinical Trials
5,537 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,696 Previous Clinical Trials
6,952,576 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,668 Previous Clinical Trials
28,005,052 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what demographic is this experiment open?

"This study is targeting 30 patients aged 50 to 80 with documented cognitive decline. In addition, applicants must have a proficient command of the English language; access to internet and Wi-Fi at training locations; be medically cleared for moderate intensity exercise; possess normal visual acuity (or corrected); adequate hearing and motor capacity to use mobile devices/computers; and demonstrate they can self-administer mSIM interventions."

Answered by AI

To what extent has this clinical trial been administered to test subjects?

"Affirmative. The information presented on clinicaltrials.gov alludes to the fact that this medical trial is currently looking for participants and has been ever since October 1st 2019, with recent updates having taken place March 30th 2022. There are only 30 slots available at one site."

Answered by AI

Are any openings currently available for this experiment?

"Indeed. Data on clinicaltrials.gov indicates that this study is open to new candidates, which was initially posted in October 2019 and most recently updated during March 2022. It requires 30 participants from one medical centre for the trial's completion."

Answered by AI

Is this investigation amenable to participants aged 45 or older?

"This trial is specifically looking for participants between the ages of 50 and 80. However, there are 24 studies that accept minors while 533 trials take on individuals beyond retirement age."

Answered by AI
Recent research and studies
~2 spots leftby Apr 2025